SAN DIEGO — Patients with hepatitis B at particular risk for bone and renal harm from tenofovir disoproxil fumarate (TDF; Viread, Gilead Sciences) might benefit from a switch to tenofovir alafenamide ...
NÎMES, France--(BUSINESS WIRE)--Regulatory News: Advicenne (Paris:ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results